Nek3 Activators
Nek3 Activators encompass a variety of chemical compounds that indirectly enhance the functional activity of Nek3 by influencing specific signaling pathways or biological processes. Staurosporine, U0126, and LY294002 are kinase inhibitors that target protein kinases within the MAPK/ERK and PI3K/AKT pathways, respectively. The inhibition of these kinases can lead to compensatory cellular responses that enhance Nek3 activity. For example, the inhibition of MEK by U0126 disrupts the MAPK signaling, which can result in increased Nek3 activity due to pathway crosstalk and the need for cellular homeostasis.
Compounds such as Rapamycin, Roscovitine, and PF-4708671 are inhibitors of mTOR, cyclin-dependent kinases, and S6K1, respectively. These molecules play roles in regulating the cell cycle and cellular growth. By inhibiting these pathways, cells may upregulate Nek3 activity to compensate and maintain cell cycle progression. Similarly, SP600125 and SB203580, which inhibit JNK and p38 MAPK pathways, can lead to a rise in Nek3 activity as these pathways are involved in the cellular stress response, and Nek3's role may be enhanced when these pathways are suppressed. PD98059, another MEK inhibitor, by altering ERK pathway signaling, can also contribute to the enhancement of Nek3 activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A kinase inhibitor that broadly targets protein kinases, including those upstream of Nek3, leading to a compensatory increase in Nek3 activity to maintain cellular homeostasis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which can induce feedback loops that enhance AKT signaling, a pathway where Nek3 can be indirectly activated due to its involvement in cell cycle regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can increase Nek3 activity indirectly by altering the cellular growth conditions, prompting a compensatory response involving cell cycle regulators such as Nek3. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor that can lead to cell cycle arrest, which may indirectly increase Nek3 activity as part of the cellular response to maintain cell cycle progression. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
A specific inhibitor of the p70 S6 Kinase 1 (S6K1) which can lead to a compensatory response in Nek3 activity due to the role of S6K1 in the cell growth and proliferation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may result in enhanced Nek3 activity as JNK is part of stress response pathways, and Nek3 can be implicated in cellular responses to stress. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can lead to increased Nek3 activity as compensation for the inhibited stress response, as Nek3 may be involved in alternative stress pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific MEK inhibitor that can lead to increased Nek3 activity by altering the downstream ERK pathway, which may affect Nek3's role in cell cycle control. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can result in increased Nek3 activity as part of a feedback loop in the PI3K/AKT/mTOR pathway, where Nek3 may be indirectly involved. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor which can lead to increased Nek3 activity due to the complex interplay between AKT signaling and cell cycle regulation, where Nek3 is a participant. | ||||||